Further statistical issues in project prioritization in the pharmaceutical industry

Stephen Senn

doi:10.1177/009286159803200133

Further statistical issues in project prioritization in the pharmaceutical industry

Stephen Senn^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

12 Citations (Scopus)

Abstract

Various aspects of portfolio management within the pharmaceutical industry are considered. It is shown that some popular notions of risk management are incorrect. Some additional practical matters are also touched upon.

Original language	English
Pages (from-to)	253-259
Number of pages	7
Journal	Therapeutic Innovation and Regulatory Science
Volume	32
Issue number	1
DOIs	https://doi.org/10.1177/009286159803200133
Publication status	Published - Jan 1998
Externally published	Yes

Keywords

Pharmaceutical industry
Portfolio management
Statistical issues

Access to Document

10.1177/009286159803200133

Cite this

@article{b40812b64263468183c592103fc80af4,

title = "Further statistical issues in project prioritization in the pharmaceutical industry",

abstract = "Various aspects of portfolio management within the pharmaceutical industry are considered. It is shown that some popular notions of risk management are incorrect. Some additional practical matters are also touched upon.",

keywords = "Pharmaceutical industry, Portfolio management, Statistical issues",

author = "Stephen Senn",

year = "1998",

month = jan,

doi = "10.1177/009286159803200133",

language = "English",

volume = "32",

pages = "253--259",

journal = "Therapeutic Innovation and Regulatory Science",

issn = "2168-4790",

publisher = "SAGE Publications Inc.",

number = "1",

}

TY - JOUR

T1 - Further statistical issues in project prioritization in the pharmaceutical industry

AU - Senn, Stephen

PY - 1998/1

Y1 - 1998/1

N2 - Various aspects of portfolio management within the pharmaceutical industry are considered. It is shown that some popular notions of risk management are incorrect. Some additional practical matters are also touched upon.

AB - Various aspects of portfolio management within the pharmaceutical industry are considered. It is shown that some popular notions of risk management are incorrect. Some additional practical matters are also touched upon.

KW - Pharmaceutical industry

KW - Portfolio management

KW - Statistical issues

UR - http://www.scopus.com/inward/record.url?scp=0031941667&partnerID=8YFLogxK

U2 - 10.1177/009286159803200133

DO - 10.1177/009286159803200133

M3 - Review article

AN - SCOPUS:0031941667

SN - 2168-4790

VL - 32

SP - 253

EP - 259

JO - Therapeutic Innovation and Regulatory Science

JF - Therapeutic Innovation and Regulatory Science

IS - 1

ER -

Further statistical issues in project prioritization in the pharmaceutical industry

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this